The second round of stakeholder meetings with the G-BA was completed on 28th September 2023.
These meetings are crucial as they allow the GBA to gather further information that will aid in decision-making for the final coverage with evidence development (CED) study directive.
With the second round of meetings completed, it looks like the fully funded trial in Germany is moving closer to commencement.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-10
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $13.97K | 2.806M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 24223265 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7403713 | 11 |
View Market Depth
| Last trade - 12.01pm 28/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |